Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid‐derived suppressor cells. Issue 3 (3rd January 2018)

• Record Type: Journal Article
• Authors: Clements, Virginia K.; Long, Tiha; Long, Ramses; Figley, Chas; Smith, Daniel M.C.; Ostrand‐Rosenberg, Suzanne
• Other Names: Dieli Francesco guestEditor.; Mikulak Joana guestEditor.
• Is Part Of: Journal of leukocyte biology. Volume 103:Issue 3(2018)
• Page Start: 395
• Page End: 407
• Publication Date: 2018-01-03
• Subjects: immune suppression -- inflammation -- obesity -- programmed death ligand 1; Leucocytes -- Periodicals; Reticulo-endothelial system -- Periodicals; 571.96
• DOI: 10.1002/JLB.4HI0517-210R
• Languages: English
• ISSNs: 0741-5400

Abstract

Abstract: Obesity is a risk factor for cancer incidence and cancer mortality. The association of obesity and cancer is attributed to multiple factors, but the tightest linkage is with the chronic, low‐grade inflammation that accompanies obesity. Myeloid‐derived suppressor cells (MDSC) are known facilitators of cancer progression that act by suppressing the activation and function of tumor‐reactive T cells. Because MDSC quantity and function are driven by chronic inflammation, we hypothesized that MDSC may accumulate in obese individuals and facilitate tumor growth by suppressing antitumor immunity. To test this hypothesis, tumor‐bearing mice on a high fat or low fat diet (HFD or LFD) were assessed for tumor progression and the metabolic dysfunction associated with obesity. HFD enhanced the accumulation of MDSC, and the resulting MDSC had both beneficial and detrimental effects. HFD‐induced MDSC protected mice against diet‐induced metabolic dysfunction and reduced HFD‐associated inflammation, but also increased the accumulation of fat, enhanced tumor progression, and spontaneous metastasis and reduced survival time. HFD‐induced MDSC facilitated tumor growth by limiting the activation of tumor‐reactive CD8 + T cells. Leptin, an adipokine that regulates appetite satiety and is overexpressed in obesity, undergoes crosstalk with MDSC in which leptin drives the accumulation of MDSC while MDSC down‐regulate the production of leptin. Collectively, these studies demonstrate that although MDSC protect against some metabolic dysfunction associated with HFD they enhance tumor growth in HFD mice and that leptin is a key regulator linking HFD, chronic inflammation, immune suppression, and tumor progression.